Related Experiment Videos
Adolescent medicine training in pediatric residency programs
Harriette B Fox1, Margaret A McManus, Jonathan D Klein
1National Alliance to Advance Adolescent Health, Washington, DC 20006, USA. hfox@thenationalalliance.org
Pediatrics
|December 9, 2009
Summary
Pediatric residency training in adolescent medicine shows significant variation and gaps across the US. Improving block rotations and integrating adolescent care into continuity clinics are crucial for better training.
Area of Science:
- Medical Education
- Adolescent Health
- Pediatrics
Background:
- Adolescent medicine training is a critical component of pediatric residency.
- Variations in training can impact the quality of care for adolescent patients.
Purpose of the Study:
- To assess the current state of pediatric residency training in adolescent medicine.
- To identify gaps and variations in ambulatory care training experiences.
Main Methods:
- Conducted two national surveys: one of pediatric residency program directors and another of adolescent medicine faculty.
- Collected descriptive and qualitative data on training content and workforce issues.
Main Results:
- Well-covered topics include normal development, interviewing, and sexual issues; least covered are violence, safety, sports medicine, and chronic illness.
- Shortages of specialists and inconsistent training structures (rotation timing, clinic sites, services) limit training quality.
- Lack of continuity clinic experience with adolescents hinders relationship-building.
Conclusions:
- Significant variations and gaps exist in US pediatric residency adolescent medicine training.
- Recommendations include improving block rotations, integrating adolescent care into continuity and specialty clinics, and defining core competencies.
Related Concept Videos
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
01:29Drug Dosing: Infants and Children
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
01:28Dosage Regimens: Designs and Approaches
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...